Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel green synthesis of ethyl 2-acetyl-3-nitromethylene-5-methyl-hexanoate using recyclable DES solvent, offering high yield and cost efficiency.
Patent CN110803994B reveals a green DES-based route for pregabalin intermediates. Discover how this technology enables cost reduction in API manufacturing and reliable supply.
Advanced synthesis of Tiaprofenic Acid via patent CN102432591B. Delivers high-purity NSAID intermediates with optimized cost reduction in API manufacturing and supply reliability.
Patent CN112707901A reveals a cost-effective resolution method for moxifloxacin side chains using gulonic acid, offering >98% ee and simplified manufacturing for reliable API intermediate supply.
Patent CN110803993B reveals a green DES-based synthesis for pregabalin intermediates, offering high yields, recyclable solvents, and scalable mechanochemical processing for cost-effective manufacturing.
Patent CN111285860B reveals novel indole-triazole hybrids with potent antibacterial activity, offering reliable agrochemical intermediate supply and streamlined manufacturing processes.
Novel patent CN115160172B details high-yield iopromide synthesis. Offers cost reduction and supply chain reliability for contrast agent manufacturing.
Advanced crystallization method boosts Oxiracetam purity to 98%. Offers cost-effective scalable solutions for pharmaceutical intermediate supply chains globally.
Patent CN116478087B enables high-purity sodium picosulfate intermediate production with improved yield and supply chain reliability for pharmaceutical manufacturing.
Patent CN102731316B reveals a safer sulfonyl protection route for 1,2-N,N'-dimethylcyclohexanediamine, offering high purity and industrial scalability for pharmaceutical supply chains.
Patent CN103059048A details a novel BSA-mediated silylation method for Cefpiramide acid, offering superior purity and homogeneous reaction conditions for pharmaceutical manufacturing.
Optimized synthesis patent CN104672281B ensures high purity and yield. Reliable supply chain for antiviral API manufacturing with cost-effective processes.
Advanced monochiral metal-organic framework technology enables high-efficiency chiral separation and photoinduction, offering cost-effective solutions for pharmaceutical manufacturing.
Novel synthetic route for 25-hydroxyvitamin D3 offering high yield and scalable manufacturing for pharmaceutical supply chains and global procurement.
Novel synthesis route using cheap phytosterol reduces costs and improves yield for steroid drug intermediates ensuring supply chain stability.
Patent CN109053590B reveals a high-yield triphosgene route for 4,6-dichloro-2-aminopyrimidine, offering significant cost reduction and simplified purification for agrochemical manufacturing.
Patent CN120098054A details ion exchange resin catalysis for high-purity impurity synthesis ensuring supply chain stability and significant cost efficiency for pharmaceutical manufacturers.
Patent CN108727212B details a cost-effective triphosgene method for mirabegron intermediate synthesis, offering high purity and reduced waste for pharmaceutical manufacturing.
Novel ammonium alkyl acetate method for AcHMF. High yield, base-free. Cost-effective supply chain solution for global buyers.
Patent CN113501871B reveals a novel solid-liquid phase method for dasiglucagon. Enhance purity and yield for reliable supply chain integration.